Search Within

Donna Lisa

Formats
  1. Meeting Abstract (8)
  2. Journal Article (5)
Groups
  1. Department of Medicine (13)
  2. Head and Neck Service (13)
  3. Neuroradiology Service (13)
  4. Radiology, Department of (13)
  5. Solid Tumor Oncology Division (13)
  6. Biostatistics Service (7)

More Groups

People
  1. David Pfister (13)
  2. Eric Sherman (12)
  3. Matthew Fury (12)
  4. Sofia Haque (11)
  5. Ronglai Shen (7)
  6. Ashok Shaha (5)

More People

Years
  1. 2013 (2)
  2. 2012 (4)
  3. 2011 (1)
  4. 2010 (3)
  5. 2009 (3)
Publications
  1. Journal of Clinical Oncology (8)
  2. Cancer (1)
  3. Cancer Chemotherapy and Pharmacology (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. Journal of the National Comprehensive Cancer Network (1)
  6. Thyroid (1)
Publishers
  1. American Society of Clinical Oncology (8)
  2. Elsevier Inc. (1)
  3. Harborside Press (1)
  4. Mary Ann Liebert, Inc (1)
  5. Springer (1)
  6. Wiley Blackwell (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Ho, A. L.; Rao, S.; Heguy, A.; Shen, R.; Korte, S.; Lisa, D.; Ganly, I.; more...
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma
    Journal Article

    Sherman, E. J.; Su, Y. B.; Lyall, A.; Schoder, H.; Fury, M. G.; Ghossein, R. A.; Haque, S.; Lisa, D.; Shaha, A. R.; Tuttle, R. M.; more...
    Thyroid (2013)

    Fulltext@MSK | Save
  • A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Ho, A. L.; Rao, S. S.; Shen, R.; Korte, S. H.; Lisa, D. M.; Ganly, I.; Katabi, N.; Patel, S. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Lisa, D.; Agarwal, N.; Algazy, K.; Brockstein, B.; Langer, C.; Lim, D. ; Mehra, R.; Rajan, S. K.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Kelly, K.; Lipson, B.; Carlson, D.; Stambuk, H.; Haque, S.; Shen, R.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Sherman, E.; Haque, S.; Korte, S.; Lisa, D.; Shen, R.; Wu, N.; Pfister, D.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II study of VEGF trap (aflibercept) in patients with radioactive iodine-refractory, positron emission tomography (PET) positive thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Haque, S.; Ghossein, R. A.; Lisa, D. M.; Schoder, H.; Baum, M. S.; Shaha, A. R.; Tuttle, R. M.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Pfister, D. G.; Haque, S.; Stambuk, H.; Lisa, D. M.; Shen, R.; Carlson, D.; Fury, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Wu, N.; Haque, S.; Lisa, D. M.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save